IL-6 is abundantly present in the TME, and an abnormally activated IL-6/STAT3 signaling pathway can play a role in the occurrence and development of HCC by affecting tumor cell proliferation, migration, invasion, angiogenesis, and apoptosis (36, 37). The gene discussed is IL6; the disease is hepatocellular carcinoma.